Guideline-Concordance With Durvalumab in Stage 3 Non-Small Cell Lung Cancer: A Single Institution ExperienceSeptember 6, 2019Lung Cancer
Patients With Stage I NSCLC Who Are Not Treated with Either Surgical Resection or Radiation TherapySeptember 6, 2019Lung Cancer
Low-Dose Screening CT for Lung Cancer in Selected High-Risk Veterans with a Significant Smoking History: The Providence VA’s ExperienceSeptember 5, 2019Lung Cancer
Durvalumab-Induced Hyperprogressive Disease in Non-Metastatic Lung CancerSeptember 5, 2019Lung Cancer
Cardiac Tamponade in a Patient with Stage IV Lung Adenocarcinoma Treated with PembrolizumabSeptember 5, 2019Lung Cancer
Use of Palliative Radiotherapy for Stage IV Lung Cancer Patients with Thoracic Symptoms in the Veterans Health Administration (VHA)September 5, 2019Lung Cancer
HIV drug may enhance efficacy of chemoradiation in locally advanced lung cancerAugust 29, 2019Lung CancerOncology
Timely Diagnosis of Lung Cancer in a Dedicated VA Referral Unit with Endobronchial Ultrasound Capability (FULL)August 19, 2019Lung CancerOncology
Immune-related toxicities, hospitalization common with checkpoint inhibitor therapyAugust 12, 2019Lung CancerHead & Neck/Thyroid Cancers
Bevacizumab or pemetrexed, but not both, efficacious for NSCLC maintenanceAugust 7, 2019Lung CancerOncology
COPD adds complexity to shared decision making for LDCT lung cancer screeningAugust 5, 2019Lung CancerOncology
